Supernus Pharmaceuticals (SUPN) Profit After Tax (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Profit After Tax of -$58.4 million for Q2 2026, down 359.44% year-over-year from $22.5 million in Q2 2025, and down 2445.62% on a QoQ basis from -$2.3 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Profit After Tax (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Profit After Tax for 16 years, with the latest figure at -$58.4 million in Q2 2026.
- Profit After Tax for Q2 2026 came in at -$58.4 million, down 359.44% year-over-year; the trailing twelve-month figure through Jun 2026 was -$109.9 million (down 270.37% YoY), and the FY2025 annual result was -$38.6 million, down 152.19% from the prior year.
- Profit After Tax fell to -$58.4 million in Q2 2026, from -$2.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $38.5 million in Q3 2024 and troughed at -$58.4 million in Q2 2026.
- A 5-year average of $2.0 million and a median of $1.5 million in 2022 frame the typical range for Profit After Tax.
- The widest annual swing landed in 2024, when Profit After Tax soared 2496.63%; it then sank 9637.9% in 2025.
- A 5-year view of Profit After Tax shows it stood at $25.5 million in 2022, then tumbled by 95.39% to $1.2 million in 2023, then jumped by 1204.51% to $15.3 million in 2024, then tumbled by 126.78% to -$4.1 million in 2025, then sank by 1321.95% to -$58.4 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$58.4 million in Q2 2026, -$2.3 million in Q1 2026, and -$4.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.73 Bn | 2.36 Bn | 185.39 Mn | -58.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58.37 Mn |
| Mar 31, 2026 | -211,000.00 |
| Dec 31, 2025 | -4.11 Mn |
| Sep 30, 2025 | -45.12 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 15.33 Mn |
| Sep 30, 2024 | 38.50 Mn |
| Jun 30, 2024 | 19.92 Mn |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -15.98 Mn |
| Jun 30, 2023 | -831,000.00 |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 25.48 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 7.87 Mn |
| Mar 31, 2022 | 25.62 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 21.56 Mn |